Haleon recalls cough syrups due to microbial contamination

Betsy Goodfellow | January 25, 2024 | News story | Medical Communications Haleon, Pharmacy, cough syrup, microbial contamination 

The US Food and Drug Administration (FDA) has shared an announcement from Haleon detailing the voluntary recall of eight lots of its Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult cough syrups due to microbial contamination.

Use by most non-immunocompromised consumers would likely not result in serious or life-threatening infection, however in immunocompromised individuals use of these products could result in severe adverse events such as fungemia or disseminated fungal infection. Medical intervention could be required in the occurrence of an infection from these products.

The recall covers the lots T10810 of Robitussin Honey CF Max Day Adult 4oz, T08730, T08731, T08732, T08733 and T10808 of Robitussin Honey CF Max Day Adult 8oz, T08740 and T08742 of Robitussin Honey CF Max Nt Adult 8oz.

The company recommends that any adverse events should be reported to the FDA’s MedWatch Adverse Event Reporting programme, available online, by mail or by fax.

According to the announcement, “to date, Haleon has not received any reports of adverse events related to this recall.” However, the company recommends that “consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.”

Betsy Goodfellow

Related Content

No items found

Latest content